Global Silymarin Market Growth 2025-2031

Publication ID:

LPI01253597

Publication Date:

January 29, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Silymarin market size is predicted to grow from US$ 93.7 million in 2025 to US$ 114 million in 2031; it is expected to grow at a CAGR of 3.3% from 2025 to 2031.
Silymarin is a flavonolignans extracted from the milk thistle Silybum marianum (L.) gaernt. Silymarin has been shown to possess various pharmacological properties like hepatoprotective, antioxidant, antiinflammatory, anticancer, and cardioprotective activities.
The top players cover LIVERD PHARMA, TY Pharmaceutical, KEB Biotech, etc. The Top 3 players in Global Silymarin market revenue was 50.46% in 2019, while the share of top 5 players was 61.99%. TY Pharmaceutical is the leading supplier of Silymarin, the production of which reached 438 MT in 2019, accounting for about 18.81% of the Global market. Market concentration is high. Except policy affect, downstream demand is the key influence factor to the market.
The 鈥淪ilymarin Industry Forecast鈥� looks at past sales and reviews total world Silymarin sales in 2024, providing a comprehensive analysis by region and market sector of projected Silymarin sales for 2025 through 2031. With Silymarin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Silymarin industry.
This Insight Report provides a comprehensive analysis of the global Silymarin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Silymarin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Silymarin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Silymarin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Silymarin.
This report presents a comprehensive overview, market shares, and growth opportunities of Silymarin market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Silymarin Extracted by Acetone
Silymarin Extracted by Ethyl Acetate
Silymarin Extracted by Ethanol
Water Soluble Silymarin
Segmentation by Application:
Pharma and Healthcare
Food Additives
Cosmetic and Skin Care
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
LIVERD PHARMA
Huacheng Pharmaceutical
TY Pharmaceutical
Teva API
KEB Biotech
Shengbo Silymarin
Panjin Fengrui
Jiaherb
Key Questions Addressed in this Report
What is the 10-year outlook for the global Silymarin market?
What factors are driving Silymarin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Silymarin market opportunities vary by end market size?
How does Silymarin break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Silymarin Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Silymarin by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Silymarin by Country/Region, 2020, 2024 & 2031
2.2 Silymarin Segment by Type
2.2.1 Silymarin Extracted by Acetone
2.2.2 Silymarin Extracted by Ethyl Acetate
2.2.3 Silymarin Extracted by Ethanol
2.2.4 Water Soluble Silymarin
2.3 Silymarin Sales by Type
2.3.1 Global Silymarin Sales Market Share by Type (2020-2025)
2.3.2 Global Silymarin Revenue and Market Share by Type (2020-2025)
2.3.3 Global Silymarin Sale Price by Type (2020-2025)
2.4 Silymarin Segment by Application
2.4.1 Pharma and Healthcare
2.4.2 Food Additives
2.4.3 Cosmetic and Skin Care
2.4.4 Others
2.5 Silymarin Sales by Application
2.5.1 Global Silymarin Sale Market Share by Application (2020-2025)
2.5.2 Global Silymarin Revenue and Market Share by Application (2020-2025)
2.5.3 Global Silymarin Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Silymarin Breakdown Data by Company
3.1.1 Global Silymarin Annual Sales by Company (2020-2025)
3.1.2 Global Silymarin Sales Market Share by Company (2020-2025)
3.2 Global Silymarin Annual Revenue by Company (2020-2025)
3.2.1 Global Silymarin Revenue by Company (2020-2025)
3.2.2 Global Silymarin Revenue Market Share by Company (2020-2025)
3.3 Global Silymarin Sale Price by Company
3.4 Key Manufacturers Silymarin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Silymarin Product Location Distribution
3.4.2 Players Silymarin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Silymarin by Geographic Region
4.1 World Historic Silymarin Market Size by Geographic Region (2020-2025)
4.1.1 Global Silymarin Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Silymarin Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Silymarin Market Size by Country/Region (2020-2025)
4.2.1 Global Silymarin Annual Sales by Country/Region (2020-2025)
4.2.2 Global Silymarin Annual Revenue by Country/Region (2020-2025)
4.3 Americas Silymarin Sales Growth
4.4 APAC Silymarin Sales Growth
4.5 Europe Silymarin Sales Growth
4.6 Middle East & Africa Silymarin Sales Growth
5 Americas
5.1 Americas Silymarin Sales by Country
5.1.1 Americas Silymarin Sales by Country (2020-2025)
5.1.2 Americas Silymarin Revenue by Country (2020-2025)
5.2 Americas Silymarin Sales by Type (2020-2025)
5.3 Americas Silymarin Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Silymarin Sales by Region
6.1.1 APAC Silymarin Sales by Region (2020-2025)
6.1.2 APAC Silymarin Revenue by Region (2020-2025)
6.2 APAC Silymarin Sales by Type (2020-2025)
6.3 APAC Silymarin Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Silymarin by Country
7.1.1 Europe Silymarin Sales by Country (2020-2025)
7.1.2 Europe Silymarin Revenue by Country (2020-2025)
7.2 Europe Silymarin Sales by Type (2020-2025)
7.3 Europe Silymarin Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Silymarin by Country
8.1.1 Middle East & Africa Silymarin Sales by Country (2020-2025)
8.1.2 Middle East & Africa Silymarin Revenue by Country (2020-2025)
8.2 Middle East & Africa Silymarin Sales by Type (2020-2025)
8.3 Middle East & Africa Silymarin Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Silymarin
10.3 Manufacturing Process Analysis of Silymarin
10.4 Industry Chain Structure of Silymarin
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Silymarin Distributors
11.3 Silymarin Customer
12 World Forecast Review for Silymarin by Geographic Region
12.1 Global Silymarin Market Size Forecast by Region
12.1.1 Global Silymarin Forecast by Region (2026-2031)
12.1.2 Global Silymarin Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Silymarin Forecast by Type (2026-2031)
12.7 Global Silymarin Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 LIVERD PHARMA
13.1.1 LIVERD PHARMA Company Information
13.1.2 LIVERD PHARMA Silymarin Product Portfolios and Specifications
13.1.3 LIVERD PHARMA Silymarin Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 LIVERD PHARMA Main Business Overview
13.1.5 LIVERD PHARMA Latest Developments
13.2 Huacheng Pharmaceutical
13.2.1 Huacheng Pharmaceutical Company Information
13.2.2 Huacheng Pharmaceutical Silymarin Product Portfolios and Specifications
13.2.3 Huacheng Pharmaceutical Silymarin Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Huacheng Pharmaceutical Main Business Overview
13.2.5 Huacheng Pharmaceutical Latest Developments
13.3 TY Pharmaceutical
13.3.1 TY Pharmaceutical Company Information
13.3.2 TY Pharmaceutical Silymarin Product Portfolios and Specifications
13.3.3 TY Pharmaceutical Silymarin Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 TY Pharmaceutical Main Business Overview
13.3.5 TY Pharmaceutical Latest Developments
13.4 Teva API
13.4.1 Teva API Company Information
13.4.2 Teva API Silymarin Product Portfolios and Specifications
13.4.3 Teva API Silymarin Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Teva API Main Business Overview
13.4.5 Teva API Latest Developments
13.5 KEB Biotech
13.5.1 KEB Biotech Company Information
13.5.2 KEB Biotech Silymarin Product Portfolios and Specifications
13.5.3 KEB Biotech Silymarin Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 KEB Biotech Main Business Overview
13.5.5 KEB Biotech Latest Developments
13.6 Shengbo Silymarin
13.6.1 Shengbo Silymarin Company Information
13.6.2 Shengbo Silymarin Silymarin Product Portfolios and Specifications
13.6.3 Shengbo Silymarin Silymarin Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Shengbo Silymarin Main Business Overview
13.6.5 Shengbo Silymarin Latest Developments
13.7 Panjin Fengrui
13.7.1 Panjin Fengrui Company Information
13.7.2 Panjin Fengrui Silymarin Product Portfolios and Specifications
13.7.3 Panjin Fengrui Silymarin Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Panjin Fengrui Main Business Overview
13.7.5 Panjin Fengrui Latest Developments
13.8 Jiaherb
13.8.1 Jiaherb Company Information
13.8.2 Jiaherb Silymarin Product Portfolios and Specifications
13.8.3 Jiaherb Silymarin Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Jiaherb Main Business Overview
13.8.5 Jiaherb Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂